TNBC

Adjuvant Carboplatin and PARP Inhibitor Combination Trials in TNBC

Rebecca Shatsky, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Impact of ADCs in Early TNBC Treatment

Mariam Haji Ahmad, MBBCh, Alexis Levee, MD

ADCs in TNBC: Current Data and Unanswered Questions

Pietro De Placido, MD, Dionisia Quiroga, DO, PhD

Anti-TROP-2 ADCs in PD-L1-Negative TNBC

Alexis Levee, MD, Paolo Tarantino, MD

SABCS 2025: Clarifying Where Sacituzumab Govitecan Fits in the Breast Cancer Treatment Landscape

Erika Hamilton, MD, FASCO, Dionisia Quiroga, DO, PhD